- Home
- EFSI vs GNLX Comparison
EFSI vs GNLX Comparison
Compare EFSI & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFSI
- GNLX
- Stock Information
- Founded
- EFSI 1881
- GNLX 2001
- Country
- EFSI United States
- GNLX United States
- Employees
- EFSI N/A
- GNLX N/A
- Industry
- EFSI Major Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- EFSI Finance
- GNLX Health Care
- Exchange
- EFSI Nasdaq
- GNLX Nasdaq
- Market Cap
- EFSI 167.5M
- GNLX 184.4M
- IPO Year
- EFSI N/A
- GNLX 2023
- Fundamental
- Price
- EFSI $32.75
- GNLX $4.81
- Analyst Decision
- EFSI
- GNLX Strong Buy
- Analyst Count
- EFSI 0
- GNLX 4
- Target Price
- EFSI N/A
- GNLX $18.25
- AVG Volume (30 Days)
- EFSI 10.3K
- GNLX 331.4K
- Earning Date
- EFSI 01-01-0001
- GNLX 03-31-2025
- Dividend Yield
- EFSI 3.79%
- GNLX N/A
- EPS Growth
- EFSI 62.68
- GNLX N/A
- EPS
- EFSI 4.32
- GNLX N/A
- Revenue
- EFSI $70,233,000.00
- GNLX $8,000.00
- Revenue This Year
- EFSI N/A
- GNLX N/A
- Revenue Next Year
- EFSI N/A
- GNLX N/A
- P/E Ratio
- EFSI $7.58
- GNLX N/A
- Revenue Growth
- EFSI 11.27
- GNLX N/A
- 52 Week Low
- EFSI $27.02
- GNLX $1.60
- 52 Week High
- EFSI $36.93
- GNLX $8.67
- Technical
- Relative Strength Index (RSI)
- EFSI N/A
- GNLX 58.52
- Support Level
- EFSI N/A
- GNLX $4.62
- Resistance Level
- EFSI N/A
- GNLX $5.76
- Average True Range (ATR)
- EFSI 0.00
- GNLX 0.57
- MACD
- EFSI 0.00
- GNLX -0.03
- Stochastic Oscillator
- EFSI 0.00
- GNLX 59.96
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending, and Wealth Management. It generates a majority of its revenue from the Community Banking segment.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.